Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Details for Australian Patent Application No. 2005303773 (hide)

Owner BioXell SpA

Inventors Penna, Giuseppe; Adorini, Luciano

Agent Davies Collison Cave

Pub. Number AU-A-2005303773

PCT Pub. Number WO2006/051106

Priority 60/668,408 04.04.05 US; 0424965.2 12.11.04 GB

Filing date 11 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/051106 Priority application(s): WO2006/051106

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303777-Stable formulations of insulinotropic peptides

2005303765-Tubular reactor with packing